Literature DB >> 9160270

An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection.

M A Ritter1, C I Furtek, M W Lo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9160270     DOI： 10.1016/s0731-7085(96)01948-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN： 0731-7085            Impact factor:   3.935


× No keyword cloud information.
  9 in total

1.  Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.

Authors:  Jung-woo Bae; Chang-ik Choi; Mi-jeong Kim; Da-hee Oh; Seul-ki Keum; Jung-in Park; Bo-hye Kim; Hye-kyoung Bang; Sung-gon Oh; Byung-sung Kang; Hyun-joo Park; Hae-deun Kim; Ji-hey Ha; Hee-jung Shin; Young-hoon Kim; Han-sung Na; Myeon-woo Chung; Choon-gon Jang; Seok-yong Lee
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

2.  Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.

Authors:  Agneta Wennerholm; Anna Nordmark; Maria Pihlsgård; Margarita Mahindi; Leif Bertilsson; Lars L Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2006-06-17       Impact factor: 2.953

3.  Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Authors:  H-H Sherry Chow; Linda L Garland; Chiu-Hsieh Hsu; Donna R Vining; Wade M Chew; Jessica A Miller; Marjorie Perloff; James A Crowell; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-17

4.  RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form.

Authors:  K Srinivasa Rao; K Srinivas
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

5.  Effect of the single CYP2C9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects.

Authors:  Kazuishi Sekino; Takahiro Kubota; Yuko Okada; Yasuhiko Yamada; Koujirou Yamamoto; Ryuya Horiuchi; Kenjirou Kimura; Tatsuji Iga
Journal:  Eur J Clin Pharmacol       Date:  2003-09-19       Impact factor: 2.953

6.  Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers.

Authors:  Yang Han; Dong Guo; Yao Chen; Yu Chen; Zhi-Rong Tan; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2009-02-17       Impact factor: 2.953

7.  Novel and validated titrimetric method for determination of selected angiotensin-II-receptor antagonists in pharmaceutical preparations and its comparison with UV spectrophotometric determination.

Authors:  Shrikant H Patil; Minakshi V Janjale
Journal:  J Pharm Anal       Date:  2012-04-09

8.  Stability-indicating Reversed-phase Liquid Chromatographic Method for Simultaneous Determination of Losartan Potassium and Ramipril in Tablets.

Authors:  S Kollipara; G Bende; Y Bansal; R Saha
Journal:  Indian J Pharm Sci       Date:  2012-05       Impact factor: 0.975

9.  Sensitive and accurate estimation of losartan potassium formulation by high-performance thin-layer chromatography.

Authors:  Muralidharan Selvadurai; Subramaniya Nainar Meyyanathan
Journal:  Pharm Methods       Date:  2011-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.